NIPS Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium During a conference call, company executives also discussed results from the SMART NIPT trial and their outlook for Natera's three businesses. Natera Revenues Grow 35 Percent in Q4 The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million. Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium In a study involving 1,300 blood samples from pregnant women, Myriad researchers demonstrated that their method could increase the fetal fraction for almost all. Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium The company plans to show new data for its Signatera oncology test at three upcoming conferences this year, including in breast cancer and bladder cancer. Natera Q3 Revenues Up 26 Percent on Increased Testing Volumes Product revenues increased 39 percent year over year to $93.3 million, while license and other revenues were down 56 percent to $4.9 million. Oct 26, 2020 Yourgene H1 Revenues Up 5 Percent Oct 8, 2020 Centene Expands Coverage of Natera NIPT to All Pregnant Women Sep 17, 2020 SVB Leerink Initiates Coverage of Natera With Outperform Rating Sep 11, 2020 Natera Prices $250M Public Stock Offering Aug 17, 2020 ACOG Guidelines Recommend NIPT for All Pregnancies Regardless of Risk Jul 7, 2020 Progenity Asks Court to Declare Non-Infringement of Natera Patents Jun 17, 2020 Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents May 12, 2020 Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal May 6, 2020 Natera Q1 Revenues Grow 41 Percent Apr 20, 2020 Yourgene Health Fiscal 2020 Revenues Up 86 Percent Apr 14, 2020 Natera Prices $250M Senior Notes Offering Apr 13, 2020 Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering Feb 5, 2020 Medical Organizations Form Reproductive Genetics Technology Consortium Dec 17, 2019 PerkinElmer Aims to Attract Vanadis NIPT Customers Through Service, Validation Studies Premium Nov 8, 2019 Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains Premium Nov 6, 2019 Natera Reports 19 Percent Increase in Q3 Revenues Nov 5, 2019 FindGene Noninvasive Prenatal Screening Kit Gets Approval from Chinese Regulators Oct 23, 2019 National Council on Disability Recommends More Regulation of NIPT Oct 10, 2019 LabCorp Shows Improved Performance for NIPT in Multifetal Pregnancies but Outcome Data Sparse Premium Sep 19, 2019 Germany's Publicly Funded Insurance to Cover NIPT Under Limited Circumstances Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.